본문 바로가기
KERD
논문KCI 등재

후테논낭하 트리암시놀론 주입 후 발생한 안압 상승에서 트리암시놀론의 수술적 제거

Surgical Removal of Sub-Tenon Triamcinolone Acetonide in Cases of Increased Intraocular Pressure after Sub-Tenon Injection

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

목적: 후테논낭하 트리암시놀론 주사 후 발생한 안압 상승에서 트리암시놀론의 수술적 제거로 안압이 정상화된 증례에 대해 보고하고자 한다. 증례요약: 당뇨황반부종으로 인해 후테논낭하 트리암시놀론(40 mg)을 주사한 3명의 환자에서 술 후 급격한 안압 상승으로 최대한의약물치료를 하였으나 반응하지 않았다. 3명의 증례 모두에서 앞방각은 열려 있었고 홍채 및 앞방각 신생혈관은 관찰되지 않았다. 세극등 현미경 검사에서 하부 후테논낭하에 트리암시놀론의 침착이 관찰되었다. 트리암시놀론의 수술적 제거 후 안압강하제의 사용 없이안압이 정상으로 유지되었다. 결론: 후테논낭하 트리암시놀론 주사 후 발생한 안압 상승에서 안압강하제의 치료로도 안압이 조절되지 않는 경우에는 트리암시놀론의수술적 제거를 고려해볼 수 있을 것이다.

Abstract

Purpose: To report cases of the surgical removal of sub-Tenon triamcinolone acetonide to control increased intraocular pressure after sub-Tenon triamcinolone acetonide injection Case summary: Three patients had no response to maximal medical treatment to control suddenly increased intraocular pressure after sub-Tenon triamcinolone acetonide (40 mg) injection to treat diabetic macular edema. The anterior chamber angle was open in all patients, and there was no neovascularization in the iris or anterior chamber angle. Slit lamp biomicroscopy showed deposition of triamcinolone acetonide in the inferior sub-Tenon area. Intraocular pressure was decreased within the normal range without any medication after removal of triamcinolone acetonide precipitates. Conclusions: Surgical removal of sub-Tenon triamcinolone acetonide can be as a primary treatment option in cases of increased intraocular pressure which shows no response to maximal medical treatment after sub-Tenon triamcinolone acetonide injection.

참고문헌 (35)

  1. Choi YJ, "Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema", Korean J Ophthalmol, 20, pp.205~209 (2006)
  2. Ozdek S, "Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion", Ophthalmic Res, 40, pp.26~31 (2008)
  3. 김윤정, "포도막염 환자에 대한 후테논낭하 스테로이드 주사 치료의 효과와 합병증", 대한안과학회지, 44(1), pp.11~72 (2003), 대한안과학회
  4. Seung Youn Jea, "Triamcinolone-Induced Intraocular Pressure Elevation: Intravitreal Injection for Macular Edema and Posterior Subtenon Injection for Uveitis", Korean Journal of Ophthalmology, 20(2), pp.99~103 (2006), 대한안과학회
  5. Giles CL, "Bulbar perforation during periocular injection of corticosteroids", Am J Ophthalmol, 77, pp.438~441 (1974)
  6. Ellis PP, "Occlusion of the central retinal artery after retrobulbar corticosteroid injection", Am J Ophthalmol, 85, pp.352~356 (1978)
  7. Nozik RA., "Orbital rim fat atrophy after repository periocular corticosteroid injection", Am J Ophthalmol, 82, pp.928~930 (1976)
  8. Kusaka S, "Orbital infection following posterior subtenon triamcinolone injection", Acta Ophthalmol Scand, 85, pp.692~693 (2007)
  9. Oh IK, "Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide", GRAEF ARCH CLIN EXP OPHTHAL, 245, pp.164~166 (2007), Springer-Verlag
  10. Kuo HK, "Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis", Chang Gung Med J, 28, pp.85~89 (2005)
  11. Lafranco Dafflon ML, "Posterior sub-Tenon’s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects", Graefe’s Arch Clin Exp Ophthalmol, 237, pp.289~295 (1999)
  12. Bui Quoc E, "Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis", J Fr Ophtalmol, 25, pp.1048~1056 (2002)
  13. Mueller AJ, "The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure", Am J Ophthalmol, 125, pp.158~163 (1998)
  14. Helm CJ, "The effect of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis", Am J Ophthalmol, 120, pp.55~64 (1995)
  15. Yamamoto Y, "Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection", Can J Ophthalmol, 43, pp.42~47 (2008)
  16. Iwao K, "Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection", J Glaucoma, 16, pp.251~256 (2007)
  17. Hirooka K, "Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone", Jpn J Ophthalmol, 50, pp.235~238 (2006)
  18. Shimura M, "Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure", Graefes Arch Clin Exp Ophthalmol, 247, pp.907~912 (2009)
  19. Inatani M, "Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study", Am J Ophthalmol, 145, pp.676~681 (2008)
  20. Levin DS, "Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation", Am J Ophthalmol, 133, pp.196~202 (2002)
  21. 김웅재, "유리체내 트리암시놀론 주사 후 시행한 후테논낭하 트리암시놀론 주입술에서의 안압 상승", 대한안과학회지, 49(1), pp.91~97 (2008), 대한안과학회
  22. Wordinger RJ, "Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma", Prog Retin Eye Res, 18, pp.629~667 (1999)
  23. Hernandez MR, "Glucocorticoid target cells in human outflow pathway: autopsy and surgical specimens", Invest Ophthalmol Vis Sci, 24, pp.1612~1616 (1983)
  24. Tawara A, "Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid- induced glaucoma", Graefes Arch Clin Exp Ophthalmol, 246, pp.1021~1028 (2008)
  25. Clark AF, "The role of steroids in outflow resistance", Exp Eye Res, 88, pp.752~759 (2009)
  26. Hirano Y, "Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes", Jpn J Ophthalmol, 53, pp.519~522 (2009)
  27. Herschler J, "Increased intraocular pressure induced by repository corticosteroids", Am J Ophthalmol, 82, pp.90~93 (1976)
  28. Okka M, "Control of steroid-induced glaucoma with surgical excision of sub-Tenon triamcinolone acetonide deposits: a clinical and biochemical approach", Can J Ophthalmol, 45, pp.621~626 (2010)
  29. Yuki K, "Selective laser trabeculoplasty for elevated intraocular pressure following subtenon injection of triamcinolone acetonide", Clin Ophthalmol, 26, pp.247~249 (2010)
  30. Mills DW, "Depot triamcinolone-induced glaucoma", Can J Ophthalmol, 21, pp.150~152 (1986)
  31. Aydin A, "Management of persistent glaucoma secondary to depot methylprednisolone", Ophthalmic Surg Lasers Imaging, 38, pp.399~401 (2007)
  32. Akduman L, "Treatment of persistent glaucoma secondary to periocular corticosteroids", Am J Ophthalmol, 122, pp.275~277 (1996)
  33. Kalina PH, "Biochemical quantification of triamcinolone in subconjunctival depots", Arch Ophthalmol, 113, pp.867~869 (1995)
  34. Kalina RE, "Increased intraocular pressure following subconjunctival corticosteroid administration", Arch Ophthalmol, 81, pp.788~790 (1969)
  35. Nakamura M, "Diabetes mellitus as a risk factor for glaucomatous optic neuropathy", Ophthalmologica, 219, pp.1~10 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (24건)